TY - JOUR
T1 - Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients
AU - Masumoto, Nobuo
AU - Fujii, Takuma
AU - Ishikawa, Mitsuya
AU - Mukai, Makio
AU - Ono, Akiko
AU - Iwata, Takashi
AU - Kubushiro, Kaneyuki
AU - Nozawa, Shiro
N1 - Funding Information:
We acknowledge the support of Grand-in-Aid for Scientific research (A) Japan Society for the promoter of Science and Research Grants for Life Science and Medicine, and the Keio University Medical Science Fund. We also acknowledge help from Digene and Mitsubishi Kagaku Iatron, Inc.
PY - 2004/8
Y1 - 2004/8
N2 - Objective. Human papillomavirus (HPV) infection is reported to be related to carcinogenesis in the uterine cervix. In Japan, screening for cervical cancer by cytology is performed in women over 30 years old. The purpose of this study was to determine whether there is an association between patient age and cervical neoplasia or HPV infection in Japanese women. Methods. Specimens from 881 randomly selected patients who came to our clinic were tested for HPV DNA by using Hybrid Capture II, whereas specimens from a 204-patient randomly selected subset diagnosed with cervical neoplasia were tested for HPV DNA by using polymerase chain reaction (PCR). HPV typing was performed in all the PCR-positive cases. Results. The HPV-positive rate in the 20- to 29-year-old patients (29.0% in the normal cytology/histology group and 85.5% in the abnormal group) was higher than in the 30- to 59-year-old patients, and the rate declined until age 60 when age increased. While HPV 18, HPV 52, other HPV types, and HPV types as a whole were frequently detected in 30- to 49-year-old patients, HPV 16 was detected more frequently in the younger group than the other HPV types (P = 0.03). Among the HPV 16-positive patients with cervical neoplasia, the proportion of cervical intraepithelial neoplasia (CIN) 3 cases was high (44%) in the 20- to 29-year-old group. Conclusions. Screening for cervical neoplasia by cytology should also be performed in women under 30 years old in Japan. The HPV typing could be a tool to strictly follow-up younger women who were diagnosed with CIN.
AB - Objective. Human papillomavirus (HPV) infection is reported to be related to carcinogenesis in the uterine cervix. In Japan, screening for cervical cancer by cytology is performed in women over 30 years old. The purpose of this study was to determine whether there is an association between patient age and cervical neoplasia or HPV infection in Japanese women. Methods. Specimens from 881 randomly selected patients who came to our clinic were tested for HPV DNA by using Hybrid Capture II, whereas specimens from a 204-patient randomly selected subset diagnosed with cervical neoplasia were tested for HPV DNA by using polymerase chain reaction (PCR). HPV typing was performed in all the PCR-positive cases. Results. The HPV-positive rate in the 20- to 29-year-old patients (29.0% in the normal cytology/histology group and 85.5% in the abnormal group) was higher than in the 30- to 59-year-old patients, and the rate declined until age 60 when age increased. While HPV 18, HPV 52, other HPV types, and HPV types as a whole were frequently detected in 30- to 49-year-old patients, HPV 16 was detected more frequently in the younger group than the other HPV types (P = 0.03). Among the HPV 16-positive patients with cervical neoplasia, the proportion of cervical intraepithelial neoplasia (CIN) 3 cases was high (44%) in the 20- to 29-year-old group. Conclusions. Screening for cervical neoplasia by cytology should also be performed in women under 30 years old in Japan. The HPV typing could be a tool to strictly follow-up younger women who were diagnosed with CIN.
UR - http://www.scopus.com/inward/record.url?scp=3543087359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3543087359&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2004.05.011
DO - 10.1016/j.ygyno.2004.05.011
M3 - Article
C2 - 15297196
AN - SCOPUS:3543087359
SN - 0090-8258
VL - 94
SP - 509
EP - 514
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 2
ER -